Zymedi揭示新型KARS1抑制剂,靶向癌症转移治疗
Zymedi describes new KARS1 inhibitors for cancer metastasis
生物技术与制药领域的最新动态
Zymedi describes new KARS1 inhibitors for cancer metastasis
Adlai Nortye discloses new PROTACs for STAT protein degradation
Beijing Tide Pharmaceutical reports ATR kinase inhibitors
Sichuan Kelun-Biotech Biopharmaceutical discovers new ADCs targeting CDH3
Insilico Medicine presents new KIF18A inhibitors
M&G PLC Buys 47,644 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Vanguard Group Inc. Has $16.42 Billion Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Biopharma funding to experience 'continued, albeit disciplined' recovery in 2026: PitchBook
Eagle Rock Investment Company LLC Buys 8,246 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Waters Corporation (NYSE:WAT) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
SETDB1 enables development beyond cleavage stages by extinguishing the MERVL-driven two-cell totipotency transcriptional program in the mouse embryo
Single molecule counting detects low-copy glycine receptors in hippocampal and striatal synapses
Frictional instabilities as an alternative to friction coefficient in fine touch perception
Prediction of SARS-CoV-2 transmission dynamics based on population-level cycle threshold values: An epidemic transmission and machine learning modeling study
Adjoint propagation of error signal through modular recurrent neural networks for biologically plausible learning
Synaptic footprints of time in working memory
10x Genomics Stock Climbs as Analysts Signal Growth Prospects - StocksToTrade
10x Genomics’ Growth Prospects Brightened by Strategic Advances - timothysykes.com
Agilent Technologies Stock: Quiet Rally, Hard Questions – Is The Lab Giant Still A Buy After Its C - AD HOC NEWS
More Than Beer and Cheese: Why Wisconsin Has Always Been Good Ground for Science